E-LIB Suche - Ergebnisse für: Atassi, Nazem

1

Safety, pharmacokinetics, and target engagement of a brain ..:

Agnes Hincelin‐Mery ; Xavier Nicolas ; Cathy Cantalloube...
https://doi.org/10.1111/cts.13690. , 2024

2

Safety, pharmacokinetics, and target engagement of a brain ..:

Hincelin‐Mery, Agnes ; Nicolas, Xavier ; Cantalloube, Cathy...
Clinical and Translational Science. 17 (2023) 1 - p. , 2023

Link: https://doi.org/10.1111/..

3

First-in-Human Study of Safety, Tolerability, Pharmacokinet..:

Hincelin-Mery, Agnes ; Lewanczyk, Pascale ; Cantalloube, Cathy...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

4

Effect of RIPK1 Inhibitor, SAR443820, on Serum Neurofilamen..:

Montalban, Xavier ; Kuhle, Jens ; Fox, Robert...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

5

An innovative phase 2 proof‐of‐concept trial design to eval..:

Querol, Luis ; Lewis, Richard A. ; Hartung, Hans‐Peter...
Journal of the Peripheral Nervous System. 28 (2023) 2 - p. 276-285 , 2023

Link: https://doi.org/10.1111/..

6

An innovative phase 2 proof-of-concept trial design to eval..:

Querol, Luis ; Lewis, Richard A ; Hartung, Hans-Peter...
https://discovery.ucl.ac.uk/id/eprint/10174265/1/J%20Peripheral%20Nervous%20Sys%20-%202023%20-%20Querol%20-%20An%20innovative%20phase%202%20proofofconcept%20trial%20design%20to%20evaluate%20SAR445088%20%20a.pdf. , 2023

Link: https://discovery.ucl.ac..

7

Safety, pharmacokinetics, and target engagement of a brain ..:

Hincelin‐Mery, Agnes ; Nicolas, Xavier ; Cantalloube, Cathy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10772668/. , 2023

Link: http://www.ncbi.nlm.nih...

8

The Role of the Complement System in Chronic Inflammatory D..:

Querol, Luis A. ; Hartung, Hans-Peter ; Lewis, Richard A....
Neurotherapeutics. 19 (2022) 3 - p. 864-873 , 2022

Link: https://doi.org/10.1007/..

9

Safety, pharmacokinetics and target engagement of novel RIP..:

Vissers, Maurits F. J. M. ; Heuberger, Jules A. A. C. ; Groeneveld, Geert Jan...
Clinical and Translational Science. 15 (2022) 8 - p. 2010-2023 , 2022

Link: https://doi.org/10.1111/..

10

Selective atrophy of the cervical enlargement in whole spin..:

Barry, Robert L. ; Torrado-Carvajal, Angel ; Kirsch, John E....
NeuroImage: Clinical. 36 (2022) - p. 103199 , 2022

Link: https://doi.org/10.1016/..

11

Classical Complement Pathway Inhibition in a "Human‐On‐A‐Ch..:

Rumsey, John W. ; Lorance, Case ; Jackson, Max...
Advanced Therapeutics. 5 (2022) 6 - p. , 2022

Link: https://doi.org/10.1002/..

12

Safety, pharmacokinetics and target engagement of novel RIP..:

Maurits F. J. M. Vissers ; Jules A. A. C. Heuberger ; Geert Jan Groeneveld...
https://doi.org/10.1111/cts.13317. , 2022

Link: https://doi.org/10.1111/..

13

Selective atrophy of the cervical enlargement in whole spin..:

Robert L. Barry ; Angel Torrado-Carvajal ; John E. Kirsch...
http://www.sciencedirect.com/science/article/pii/S2213158222002649. , 2022

Link: https://doi.org/10.1016/..

14

Safety, pharmacokinetics and target engagement of novel RIP..:

Vissers, Maurits F. J. M ; Heuberger, Jules A. A. C ; Groeneveld, Geert Jan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372423/. , 2022

Link: http://www.ncbi.nlm.nih...

15

NOS1AP is a novel molecular target and critical factor in T..:

Cappelli, Sara ; Spalloni, Alida ; Feiguin, Fabian...
qt0wz017kw. , 2022

Link: https://escholarship.org..